Belimumab in Patients with Chronic Lymphocytic Leukemia

Conditions

• Chronic Lymphoid Leukemia in Relapse

Interventions

• DRUG: Belimumab 200 MG/ML [Benlysta]
• DRUG: standard of care

Sponsor

University Hospital Tuebingen

Collaborators

• [object Object]